Immunotherapy in Melanoma: Role of TIGIT and LAG-3 on the antitumor immune microenvironment

Melanoma, is a malignant tumor arising from melanocytes. Given the ability of melanoma cells to inactivate lymphocytes, immunotherapy in melanoma has focused on using immune checkpoint inhibitors (ICIs) to counteract immune evasion. The lymphocyte activation gene 3 (LAG-3) and the inhibitory recepto...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Gaona Neira, Geidi Catherinne, Salazar Prieto, Shanon Daniela, Rondón Lagos, Sandra Milena
Aineistotyyppi:	Online
Kieli:	spa
Julkaistu:	Universidad Pedagógica y Tecnológica de Colombia 2023
Aiheet:	Anticuerpos monoclonales Terapia antitumoral combinada punto de control inmunitario LAG-3 TIGIT células T Monoclonal antibodies T cells immune checkpoint combined antitumor therapy
Linkit:	https://revistas.uptc.edu.co/index.php/ciencia_en_desarrollo/article/view/15041